Details

Autor(en) / Beteiligte

• Hassan, Cesare
• Quintero, Enrique
• Dumonceau, Jean-Marc
• Regula, Jaroslaw
• Brandão, Catarina
• Chaussade, Stanislas
• Dekker, Evelien
• Dinis-Ribeiro, Mario
• Ferlitsch, Monika
• Gimeno-García, Antonio
• Hazewinkel, Yark
• Jover, Rodrigo
• Kalager, Mette
• Loberg, Magnus
• Pox, Christian
• Rembacken, Bjorn
• Lieberman, David

Titel

Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline

Ist Teil von

• Endoscopy, 2013-10, Vol.45 (10), p.842-864

Ort / Verlag

Germany

Erscheinungsjahr

2013

Quelle

MEDLINE

Beschreibungen/Notizen

• The following recommendations for post-polypectomy endoscopic surveillance should be applied only after a high quality baseline colonoscopy with complete removal of all detected neoplastic lesions.1 In the low risk group (patients with 1 - 2 tubular adenomas < 10 mm with low grade dysplasia), the ESGE recommends participation in existing national screening programmes 10 years after the index colonoscopy. If no screening programme is available, repetition of colonoscopy 10 years after the index colonoscopy is recommended (strong recommendation, moderate quality evidence). 2 In the high risk group (patients with adenomas with villous histology or high grade dysplasia or ≥10 mm in size, or ≥ 3 adenomas), the ESGE recommends surveillance colonoscopy 3 years after the index colonoscopy (strong recommendation, moderate quality evidence). Patients with 10 or more adenomas should be referred for genetic counselling (strong recommendation, moderate quality evidence). 3 In the high risk group, if no high risk adenomas are detected at the first surveillance examination, the ESGE suggests a 5-year interval before a second surveillance colonoscopy (weak recommendation, low quality evidence). If high risk adenomas are detected at first or subsequent surveillance examinations, a 3-year repetition of surveillance colonoscopy is recommended (strong recommendation, low quality evidence).4 The ESGE recommends that patients with serrated polyps < 10 mm in size with no dysplasia should be classified as low risk (weak recommendation, low quality evidence). The ESGE suggests that patients with large serrated polyps (≥ 10 mm) or those with dysplasia should be classified as high risk (weak recommendation, low quality evidence).5 The ESGE recommends that the endoscopist is responsible for providing a written recommendation for the post-polypectomy surveillance schedule (strong recommendation, low quality evidence).